Colgate-Palmolive (CL) Upgraded to Equal Weight with Price Target Raised to $86
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: seekingalpha
- Balanced Risk/Reward: Following a significant slowdown in the consumer staples sector in 2025, Colgate-Palmolive is emerging with a more balanced risk/reward profile, although it still faces volume pressures in Asia Pacific and soft trends in the U.S. market.
- Rating Adjustment: Wells Fargo upgraded Colgate-Palmolive's stock rating from Underweight to Equal Weight, reflecting a reasonable view on its valuation, with the current stock price trading at a 5% discount to market averages, the lowest since before the pandemic.
- Earnings Expectations: Colgate-Palmolive is expected to report fourth-quarter results on January 30, with an anticipated profit of $0.91 per share and sales of $5.12 billion, marking a 3.6% increase from the previous year, indicating stable performance.
- Market Outlook: Despite a 12% price target increase to $86, analysts remain cautious about Colgate-Palmolive's growth prospects, citing constrained growth in emerging markets and currency fluctuations impacting pricing strategies.
Analyst Views on CL
Wall Street analysts forecast CL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CL is 87.75 USD with a low forecast of 77.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
9 Buy
6 Hold
1 Sell
Moderate Buy
Current: 81.930
Low
77.00
Averages
87.75
High
95.00
Current: 81.930
Low
77.00
Averages
87.75
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
